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Hemagglutination inhibition (HAI) is currently the most widely accepted method for the diagnosis of rubella virus infection and for evaluation of immune status (4) . However, the HAI test is time consuming to perform, certain inherent variables can affect its accuracy, and its interpretation is somewhat subjective (8, 12) . The need for a more objective, less laborious assay has resulted in the development of the indirect fluorescent-antibody test (IFA) and enzyme-linked immunosorbent assay (ELISA). These methodologies have been adapted for use in the clinical laboratory and are now available in kit form.
In the conventional rubella IFA test developed by Brown et al. , serum dilutions were added to a cover-slip culture of a cell line that was chronically infected with rubella virus (3) . After a series of incubations and washings, the endpoint titer was determined by examining each culture microscopically. An automated version of the IFA test (FIAX) was recently marketed by International Diagnostic Technology, Santa Clara, Calif. Evaluations by Brody et al. and Cremer et al. showed good correlation between FIAX and HAI, when the HAI titer was -1:64, but only fair agreement at lower HAI titers (2, 6) .
The ELISA test for rubella was first used by Voller et al., who found an overall discrepancy rate of 3.7% as compared with various HAI antibody levels (15) . The ELISA method has been used in other viral assays, and preliminary data indicate that it could be used for the diagnosis of most viral infections (9) . An almost linear relationship between viral antibody titers and ELISA optical density was demonstrated by several investigators (7, (13) (14) (15) . ELISA has been found to be objective, sensitive, specific, and more economical than current methodologies.
In this study we cence. Four standards with given titers are included in each kit. These standards were run in duplicate for better fitting of points by the microcomputer, which plotted the net fluorescence against the logarithm of the given titer. Once an acceptable straight line was obtained, the titers of the unknowns and controls were interpolated by the computer. FIAX results were reported as the inverse of the calibrated antibody titers. A titer of <8 indicates no immunity whereas a titer of -8 indicates immunity.
The manufacturers have set a maximum limit for an acceptable background fluorescence. At titers less than or equal to 16, a high background (twice the average of that obtained with the standards) will interfere with the sensitivity; for this reason 16 such specimens were eliminated from the rest of the study. This acknowledgment of sensitivity interference at high backgrounds was not a feature of the earlier kits tested by other investigators (2, 6) . For evaluating the quantitative ability of the FIAX in reference to that of the HAI, an "equivalence" titer was assigned to the continuous FIAX titers (8, 9, 10, etc.) to accommodate the twofold nature of the HAI titers (1:10, 1:20, 1:40, etc.) ( Table 1) . A difference greater than a fourfold titer between HAI and IFA was considered a disagreement and treated in the same manner as a disagreement for immune status.
ELISA. The Rubelisa kit (M. A. Bioproducts, Walkersville, Md.) was used in the ELISA study. Strips, each equipped with 10 joined cuvettes, were furnished by the manufacturer as the solid-phase component. Even-numbered cuvettes were coated with rubella antigen whereas the odd-numbered cuvettes contained background antigen. The background antigen was made up of noninfected cells and served as the blank, subtracting from the tests all color due to nonspecific binding. A 1:50 dilution of the serum was delivered to a consecutive pair of cuvettes (blank, test). The cuvettes were incubated at 23 to 24°C in a moist chamber for 2 h. After washing with buffer, alkaline phosphatase-conjugated rabbit anti-human immunoglobulin G (IgG) was added and incubated for 2 h at 23 to 24°C. The cuvettes were then thoroughly washed with buffer. After removal of the buffer, the enzyme-substrate reaction was started by the addition of the substrate, p-nitrophenyl phosphate. This step was performed on the Gilford PR-50 dispenser which is a part of a semiautomated assembly designed for ELISA assays. All fractions were read at exactly 45 min after the addition of p-nitrophenyl phosphate, at (Table 3) .
A correlation of 86.6% (253/292) was established between HAI and IFA titers at an agreement level of within -twofold titer and 99.3% (290/292) correlation within -fourfold titer (Table 5). Ten immune sera were in disagreement for their antibody titer (>fourfold) when assayed by both methods initially. This large difference in titers was corrected for 9 of 10 specimens with the repeat runs. With three of these sera, both IFA and HAI were in error initially; with the remaining six specimens, HAI was in error on the first run with three and IFA was in error with the other three. This reflected a first run error of 3.0% (6/197) with both IFA and HAI for specimens with antibody levels of >1:20 (Table  4 Table 6 . DISCUSSION The results of the comparison study indicated that there was good agreement between the HAI, IFA, and ELISA methods for detecting rubella antibodies. The specificities of IFA and ELISA in reference to HAI when evaluated at the nonimmune antibody level (<1:10) were 97. 5 and 95%, respectively. The sensitivities of both methods (IFA, ELISA) were 100 and 99.2%, respectively.
This study included ninety-five sera with -1:20 HAI antibody titer. In this category, 18 errors on the first run, involving immune status, occurred. Nine of those errors were with HAI, and the other nine were with IFA, whereas zero errors on the first run occurred with ELISA.
Other investigators reported that the majority of disagreements between HAI and other methods occurs with sera containing a low level of antibody (5, 6) . It is known that beta-lipoproteins, if not completely removed during the serum treatment procedure, will cause nonspecific VOL. 14, 1981 on November 2, 2017 by guest http://jcm.asm.org/ 
